Compare
QuidelOrtho vs West Pharmaceutical Services (QDEL vs WST)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year QuidelOrtho (QDEL) returned -60.9% and West Pharmaceutical Services (WST) +41.0%; so far this year the figures are -62.5% and +45.3%.
West Pharmaceutical Services is the larger company by market value, about 38.2 times the size of QuidelOrtho.
Revenue grew -4.5% at QDEL and +12.6% at WST over the last year.
QDEL pays no dividend. WST yields 0.22%.
Data as of the latest close. Not investment advice.
Relative performance
| QDEL | WST | |
|---|---|---|
| Price | $10.70 | $399.81 |
| 1-day | -16.67% | +1.87% |
| YTD | -62.54% | +45.31% |
| 1 year | -60.91% | +41.01% |
| 3 years | -82.31% | +24.29% |
| Market cap | $730M | $27.9B |
| P/E | — | 44.9 |
| P/S | 0.28 | 8.20 |
| P/B | 0.41 | 9.38 |
| Revenue growth | -4.50% | +12.60% |
| EPS growth | — | +32.00% |
| Gross margin % | 44.2 | 37.6 |
| Net margin % | -14.2 | 18.8 |
| ROE % | -20.6 | 21.5 |
| Debt / equity | 1.64 | 0.07 |
| FCF yield % | -16.0 | 1.6 |
| Dividend yield % | — | 0.22 |
| Beta | 2.52 | 0.66 |
| RSI (14) | 34.4 | 57.5 |
| Technical rating |